Log In Sign up
The largest database of trusted experimental protocols

Ab229440

Manufactured by R&D Systems
Visit Supplier

Ab229440 is a recombinant protein product developed by R&D Systems for research use. The product is a human VEGF-A protein.

Automatically generated - may contain errors

Lab products found in correlation

Mcs00, by R&D Systems (1 mentions) Cholesterol e assay, by Fujifilm (1 mentions) Ab208979, by Abcam (1 mentions)

2 protocols using ab229440

1

Mouse Plasma Biomarker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse plasma was isolated through centrifugation of blood at 12 000 g for 10 min at 4°C. IL-18, IL-1β, and G-CSF plasma levels were measured by ELISA (MBL International, 7625) and (Abcam, ab229440 and R&D systems MCS00), respectively. Total plasma cholesterol was determined using a cholesterol E assay (Wako, cat. no. 999–02601).
Yalcinkaya M., Fotakis P., Liu W., Endo-Umeda K., Dou H., Abramowicz S., Xiao T., Libby P., Wang N., Tall A.R, & Westerterp M. (2022). Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion. Cardiovascular Research, 119(4), 969-981.
+ Open protocol
+ Expand
2

Cytokine Profiling in Vaccinated Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercial sandwich ELISA kits were used to measure the concentrations of different cytokines in plasma from QβS100A9-vaccinated and control mice. We used kits for mouse calprotectin S100A8/9 heterodimer (R&D Systems, DY8596-05), mouse MCP-1 (Abcam, ab208979), mouse IL-1β (Abcam, ab229440) and mouse IL-6 (R&D Systems, M6000B).
Ortega-Rivera O.A., Shin M.D., Moreno-Gonzalez M.A., Pokorski J.K, & Steinmetz N.F. (2022). A single-dose Qβ VLP vaccine against S100A9 protein reduces atherosclerosis in a preclinical model. Advanced therapeutics, 5(10), 2200092.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!